After shedding its cancer business just over a decade ago, GSK’s new CEO is building back with a $10.6 billion deal

After shedding its oncology business just over a decade ago, GSK is building it back with a $10.6 billion deal. […]

You’ve never heard of it, but you very well may have it. Medical bodies develop the first guidelines to treat cardiovascular-kidney-metabolic syndrome, which likely affects 90% of Americans.

Nearly 90% of Americans meet the criteria for CKM syndrome. New guidelines have been issued for diagnosing and treating the

NEWYou can now listen to Fox News articles! A diabetes drug could help lower the risk of heart failure in

Find insight on GSK’s $10.6 billion acquisition of Nuvalent, AstraZeneca and more in the latest Market Talks covering Health Care.

NEWYou can now listen to Fox News articles! A woman with advanced Alzheimer’s disease saw significant improvements in brain function

Nearly a fifth of patients exited the survodutide trial due to adverse gastrointestinal events such as nausea, vomiting and diarrhea,

NEWYou can now listen to Fox News articles! Potentially deadly sepsis may be more likely in certain patients due to

NEWYou can now listen to Fox News articles! Potentially deadly sepsis may be more likely in certain patients due to

A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions. Source link

The Danish drugmaker said the pill hit one million prescriptions 12 weeks after reaching U.S. pharmacies and online providers, and